Paper22584792
Tumor markers in clinical practice: a review focusing on common solid cancers.
Duffy MJ. Med Princ Pract, 2013. Cited by 184 papers, by iCite.
Cite this record
ConductScience Library. Tumor markers in clinical practice: a review focusing on common solid cancers. Papers, record 22584792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22584792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Early Detection of Cancer | Major topic |
| Neoplasms | Major topic |
| CA-125 Antigen | |
| Carcinoembryonic Antigen | |
| Chorionic Gonadotropin | |
| Environmental Monitoring | |
| Humans | |
| Mucin-1 | |
| Occult Blood | |
| Prognosis | |
| Prostate-Specific Antigen | |
| alpha-Fetoproteins |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11934773 | Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. | BMJ | 2002 | https://conductscience.org/library/papers/11934773 | PubMed |
| 2 | 17954709 | American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17954709 | PubMed |
| 3 | 19297566 | Screening and prostate-cancer mortality in a randomized European study. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19297566 | PubMed |
| 4 | 20207771 | National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. | Clin Chem | 2010 | https://conductscience.org/library/papers/20207771 | PubMed |
| 5 | 15637130 | Predictive markers in breast and other cancers: a review. | Clin Chem | 2005 | https://conductscience.org/library/papers/15637130 | PubMed |
| 6 | 11792750 | Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. | J Natl Cancer Inst | 2002 | https://conductscience.org/library/papers/11792750 | PubMed |
| 7 | 16260202 | Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. | Am J Obstet Gynecol | 2005 | https://conductscience.org/library/papers/16260202 | PubMed |
| 8 | 20685042 | Use of molecular markers for predicting therapy response in cancer patients. | Cancer Treat Rev | 2011 | https://conductscience.org/library/papers/20685042 | PubMed |
| 9 | 16250051 | Management of hepatocellular carcinoma. | Hepatology | 2005 | https://conductscience.org/library/papers/16250051 | PubMed |
| 10 | 15711272 | Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. | J Urol | 2005 | https://conductscience.org/library/papers/15711272 | PubMed |
| 11 | 17222629 | Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. | J Urol | 2007 | https://conductscience.org/library/papers/17222629 | PubMed |
| 12 | 21642681 | Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. | JAMA | 2011 | https://conductscience.org/library/papers/21642681 | PubMed |
| 13 | 15591335 | A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15591335 | PubMed |
| 14 | 11355938 | Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy. | Br J Cancer | 2001 | https://conductscience.org/library/papers/11355938 | PubMed |
| 15 | 11451209 | Clinical uses of tumor markers: a critical review. | Crit Rev Clin Lab Sci | 2001 | https://conductscience.org/library/papers/11451209 | PubMed |
| 16 | 17060676 | ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/17060676 | PubMed |
| 17 | 19297565 | Mortality results from a randomized prostate-cancer screening trial. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19297565 | PubMed |
| 18 | 19282241 | Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). | Lancet Oncol | 2009 | https://conductscience.org/library/papers/19282241 | PubMed |
| 19 | 21169250 | Biologically targeted cancer therapy and marginal benefits: are we making too much of too little or are we achieving too little by giving too much? | Clin Cancer Res | 2010 | https://conductscience.org/library/papers/21169250 | PubMed |
| 20 | 16254457 | Tumor markers in breast cancer- European Group on Tumor Markers recommendations. | Tumour Biol | 2005 | https://conductscience.org/library/papers/16254457 | PubMed |
Cited by115
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 184 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964893 | Lysosomal exoglycosidases as biomarkers of systemic diseases - what's new? | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42964893 | PubMed |
| 42726768 | The impact of anxiety and affective disorders on breast cancer screening in women in Puerto Rico. | PLoS One | 2026 | https://conductscience.org/library/papers/42726768 | PubMed |
| 42682931 | The specificity trap in routine tumor biomarker interpretation: Advancing the 3PM-based clinical decision framework to benefits of patients. | EPMA J | 2026 | https://conductscience.org/library/papers/42682931 | PubMed |
| 42459895 | Purple Urine Bag Syndrome in a 26-Year-Old Woman Living with HIV and Metastatic Spinal Cord Compression: A Case Report. | Int Med Case Rep J | 2026 | https://conductscience.org/library/papers/42459895 | PubMed |
| 42449580 | Small Is Beautiful: Is ctDNA Ready for Routine Implementation in Cancer Management? | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449580 | PubMed |
| 42421031 | Regulated cell death plasticity in cancer: thresholds, reversibility, and therapeutic failure. | J Transl Med | 2026 | https://conductscience.org/library/papers/42421031 | PubMed |
| 42406175 | Comparative performance of biopolymer-supported graphitic carbon nitride nanosheets for electrochemical carcinoembryonic antigen cancer biomarker detection in serum samples using smartphone device. | Mikrochim Acta | 2026 | https://conductscience.org/library/papers/42406175 | PubMed |
| 42343071 | CT radiomics for survival risk stratification in resectable colorectal liver metastases: a multi-centre study. | Sci Rep | 2026 | https://conductscience.org/library/papers/42343071 | PubMed |
| 42214175 | Current opinions on CEA in the diagnosis and prognosis of colorectal cancer. | Transl Oncol | 2026 | https://conductscience.org/library/papers/42214175 | PubMed |
| 42005263 | Cecal Perforation Presenting as Apparent Peritoneal Carcinomatosis: Distinguishing Acute Peritonitis From Malignant Mimicry. | Cureus | 2026 | https://conductscience.org/library/papers/42005263 | PubMed |
| 41770443 | Diagnostic utility of postmortem serum tumor markers for identifying primary malignancies: A forensic evaluation of six markers. | Forensic Sci Med Pathol | 2026 | https://conductscience.org/library/papers/41770443 | PubMed |
| 41706367 | Exploring the Clinical Landscape of Long Non-coding RNAs in Cancer Diagnosis and Therapy. | Biochem Genet | 2026 | https://conductscience.org/library/papers/41706367 | PubMed |
| 41515549 | Diagnostic Value of CA-125 and Other Tumor Biomarkers in Children with Suspected Malignancy: A Retrospective Cohort Study. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41515549 | PubMed |
| 41301014 | Serological Response Patterns to Assess Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Multi-Center Observational Cohort Study. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41301014 | PubMed |
| 41132949 | An effective and affordable blood test for lung cancer early detection using four protein markers and artificial intelligence. | Transl Lung Cancer Res | 2025 | https://conductscience.org/library/papers/41132949 | PubMed |
| 40918869 | When Carcinoembryonic Antigen Misleads: A Benign Cause of Tumor Marker Elevation. | Cureus | 2025 | https://conductscience.org/library/papers/40918869 | PubMed |
| 40612003 | New breast cancer marker BF-09 is overexpressed in tumor extracts and secreted in serum. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/40612003 | PubMed |
| 40075875 | Recent Exploration of Solid Cancer Biomarkers Hidden Within Urine or Blood Exosomes That Provide Fundamental Information for Future Cancer Diagnostics. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40075875 | PubMed |
| 39939074 | Circulating biomarkers for diagnosis and response to therapies in cancer patients. | Int Rev Cell Mol Biol | 2025 | https://conductscience.org/library/papers/39939074 | PubMed |
| 39696346 | Exosomes and breast cancer angiogenesis; Highlights in intercellular communication. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39696346 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22584792
GET https://conductscience.org/api/papers/v1/22584792/references?page=2